American Marconi Wireless News

NYSE - LSE

NGG	-3.33%	83.15	$
RELX	-3.19%	40.17	$
BTI	-3.6%	60.89	$
BP	-0.38%	44.53	$
GSK	-0.16%	50.33	$
CMSC	-0.35%	20.05	$
AZN	-0.23%	186.43	$
RBGPF	0%	75.17	$
RIO	0.68%	83.73	$
RYCEF	0.3%	16.43	$
BCC	-5%	70.24	$
VOD	-2.37%	15.58	$
BCE	-1.9%	21.62	$
JRI	1.81%	11.63	$
CMSD	-0.1%	20.15	$

Featured

Katy Perry Tells Fans Ex-Husband Russell Brand 'Should Be in Jail' During UK Concert

Katy Perry has recalled a past concert moment where she told fans that her ex-husband Russell Brand 'should be in jail,' a statement that has taken on renewed significance following his recent criminal convictions. The singer made the remark during a question-and-answer session at the Blenheim Palace Festival last July, before Brand was found guilty of rape and sexual assault.

George and Amal Clooney attend New York political-comedy reading

George and Amal Clooney attended a performance at New York’s Seaview Studio where the actor took part in a reading of the political comedy Smear!

Last news

RF Industries to Report Second Quarter Results on June 15

SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / RF Industries, Ltd, (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced that it will release its second quarter fiscal year 2026 financial results after the close of the market on Monday, June 15, 2026.

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of recurrence or death and a 59% reduction in the risk of distant metastasis or death compared to KEYTRUDA aloneIntismeran autogene in combination with KEYTRUDA demonstrated an encouraging trend toward overall survival in an exploratory analysis compared to KEYTRUDA alone (HR=0.471; [95% CI, 0.165-1.345])

Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)

FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is pleased to announce the approval of its generic Rivaroxaban tablets of 2.5mg, 10mg, 15mg and 20mg for the Canadian market. Rivaroxaban is the generic equivalent of the brand name anticoagulant, Xarelto®.

American Rebel Holdings, Inc. (OTC:AREB) Proudly Announces American Rebel Light Beer - America's Patriotic Beer - Is Now Available in Central Florida Through Wayne Densch, Inc.

Wayne Densch - Central Florida's #1 Beer Distributor for Over 64 Years - Launched American Rebel Light Beer on May 1, bringing 6-Pack 16 oz Cans and 12-Pack 12 oz Cans to the Central Florida Market Following a February American Rebel Tour Bus Meeting and February 15 Contract SigningWayne Densch Has Featured American Rebel Light Beer as a New Product on Its Corporate Website and Facebook Page; Patriots Across Central Florida Can Now Raise a Cold One for God, Country, and the Constitution

Black Book to Release Highly Anticipated 2026 Vendor-Agnostic RCM KPI Results Ahead of HFMA Annual Conference 2026

Independent qualitative KPIs across 48 RCM categories will help healthcare buyers prove platform performance before purchase\, measuring user experience, functional outcomes, workflow execution, process gains, reimbursement impact, problem-solving value, automation readiness, and AI governance, without vendor influence, sponsorship, subscriptions, or pay-to-participate models.

Wellgistics Health Provides Mid-Year 2026 Corporate Outlook

Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical Drones and Health Lives Here progressRecent capital raise provides capital into late 2026, including meeting criteria for DelivMeds AI transaction funding closing conditionRecent capital raise and debt restructuring preclude the Company from issuing shares for capital raising purposes until the earlier of seven (7) months from the transaction date and thirty (30) days after effectiveness of the resale registration statement covering the underlying securities.Recent lock-up agreement to limit shares available for sale into the marketExercise of warrants embedded in recent financing would provide funding through 2029

Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress

NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that four abstracts highlighting rusfertide in polycythemia vera (PV) will be presented at the 2026 European Hematology Association Congress (EHA2026 Congress), taking place June 11-14, 2026, in Stockholm, Sweden. The presentations include analyses from the randomized, controlled Phase 3 VERIFY study, as well as long-term results from the Phase 2 REVIVE and THRIVE open-label extension studies.

Med-X Secures Strategic Relationship with Main Line Brands, Franchisor of Mosquito Authority and Pest Authority, One of the Largest Pest Control Franchise Systems in North America

Nature-Cide X2 Plus Selected as Preferred All-Natural SolutionAs Customer Demand Trends Toward Natural Pest Control Solutions, Mosquito Authority / Pest Authority Launches Company-Wide Initiative to Integrate Nature-Cide X2 Plus; Med-X to Support Rollout with Marketing, Advertising and Franchisee Education

Who Does the Best Mommy Makeover in Seattle?

The Best Mommy Makeover In Seattle Is By Dr. Javad Sajan

Who Does the Best Liposuction in Sarasota?

The Best Liposuction Is Done By Dr. Alberico Sessa

Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation

GERSTEL Strengthens Global Scientific Engagement with Bioz to Unlock Publication-Driven Insights Across Its Product Portfolio

PALO ALTO, CA / ACCESS Newswire / June 1, 2026 / Bioz, Inc., the platform converting publications into product credibility, announced its collaboration with GERSTEL, is a member of the Velaris family, which includes more than seven brands and is home to some of the world's leading laboratory automation companies, supported by the global investment firm Battery Ventures. GERSTEL is enhancing how researchers discover and engage with publication-backed validation through the implementation of Bioz Badges across its website.

InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 01

Purchase of own shares

Paris celebrates football triumph amid riot recriminations

The French capital laid out a red, white and blue carpet Sunday for Paris Saint-Germain players to mark their second straight Champions League title, amid bitter recriminations after hundreds of people were arrested and dozens of police hurt in a night of unrest.

Paris Saint-Germain players celebrate amid riot recriminations

The French capital laid on a hero's welcome Sunday for Paris Saint-Germain players to mark their second straight Champions League title, amid bitter recriminations after hundreds of people were arrested and dozens of police hurt in a night of unrest across the country.

Paris prepares hero's welcome for PSG Champions League winners under heavy security

Paris prepared a hero's welcome for Paris Saint-Germain players who won their second consecutive Champions League title with celebrations planned in the capital under heavy security after a night of revelry marred by unrest.

Two decades later, impacts from Indonesia mud volcano linger

Harwati clasped her hands and offered a prayer on the edge of a sludge lake on the Indonesian island of Java, as dozen of residents gathered to mark two decades since mud volcano eruptions began displacing thousands.

Australian researchers teach brain cells to play 'Doom'

Australian researchers have trained lab-grown brain cells on a silicon computer chip to play the nineties shooter "Doom" and say they are just scratching the surface of what the neurons could be capable of doing.

'Totally hooked': Hong Kong targets claw machine addiction

Claw machine lover Neiki Lee carefully lowers the metal jaws of a crane with a joystick into a pool of prizes, only to have the small toy slip from its clutches again and again.

Will State Marijuana Operators Get a Federal Green Light Before DEA Resolves MMJ's Seven-Year Wait?

"One DEA Schedule I laboratory registration approved. FDA INDs granted. Orphan Drug Designation awarded. Yet the cultivation application remains unresolved as patients continue to wait. This is responsible drug policy?" stated Duane Boise, CEO MMJ International Holdings.Anne Milgram is gone, and most of the architects of pharmaceutical obstruction have retired. As the June 29 rescheduling hearing approaches, the DEA must answer for a decade of systematic patient abandonment.

Trump admin walks back recent Green Card announcement

The Trump administration has walked back its announcement that non-citizens seeking permanent US residency, commonly called a Green Card, would need to return to their home country to apply, The New York Times reported.

Heatwave makes conditions 'inhumane', say inmates at overcrowded Paris suburb prison

A damp towel hangs from a barred window, a fan churns the muggy air: Inmates at the overcrowded Villepinte prison outside Paris say enduring a heatwave that has stifled France in recent days in cramped cells is "inhumane".

Canadian poison seller pleads guilty to aiding suicides, avoids murder trial

The Canadian man who sold poison to distressed people worldwide pleaded guilty on Friday to 14 counts of aiding suicide but avoided a murder trial, an outcome one victim's father branded "a disgrace."

MMJ ET AL PREPARES APPEAL CMS HEMP PROGRAM: How Can a Company With a Manufactured Pharmaceutical Soft Gel Be Told It Has "No Product"?

JUDGE McFADDEN SAID MMJ HAS "NO PRODUCT." THE RECORD SAYS OTHERWISE.How Can a Company With FDA INDs, Orphan Drug Designation, Manufactured Soft gel Capsules, and Reproducible Chemistry Be Described as Having "No Product"? asked Duane Boise, CEO MMJ International Holdings.

Canadian poison seller pleads guilty to aiding suicides

The Canadian man who helped scores of people worldwide kill themselves by selling them poison pleaded guilty on Friday to 14 counts of aiding suicide, as prosecutors said they will withdraw murder charges.

German ex-minister faces perjury charges over failed car toll plan

A former German transport minister faces a perjury trial related to a failed scheme to charge foreign motorists highway tolls, a debacle that cost the government hundreds of millions of euros.

Blue Origin rocket explodes on launch pad

Blue Origin's New Glenn rocket exploded during a test Thursday on the launch pad in Cape Canaveral, Florida, though officials said no injuries were reported from the incident.

Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform

VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC0, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta premium longevity brand, announces a proposed non-brokered private placement financing (the "Private Placement"), consisting of the issuance of an aggregate of up to 2,500,000 units of the Company (each, a "Unit"), at a price of $1.00 per Unit for aggregate gross proceeds of up to $2,500,000.

The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit

The Company reported a record quarterly billed revenue of $12.5M (CAD $17.8M) in Q1 2026, representing a YoY increase of 17% from Q1 2025.The Company achieved positive EBITDA of $0.3M (CAD $0.4M) and Adjusted EBITDA of $0.5M (CAD $0.7M) in Q1 2026, despite incremental costs associated with the ramp-up of its new manufacturing facility.The Company completed the retrofit and commenced operations at its newly leased 154,000-square-foot manufacturing facility in the southwest suburbs of Chicago, expanding production capacity for future growth.The Company completed a $3.0M ($4.3M) private placement in January 2026, strengthening its balance sheet and supporting its expansion strategy.

Black Book 2026 Payer Digital Technology Survey Establishes Rigorous 18-KPI Standard for Health Plan IT Client Satisfaction Rankings

Proprietary qualitative model evaluates payer technology, managed services, BPaaS, analytics, AI, cybersecurity, interoperability, clinical operations, administrative operations, and transformation partners through verified user experience and operational evidence

Dr. Ran Rubinstein Brings BioRePeel to Newburgh, NY and Montvale, NJ

Dr. Ran Rubinstein introduces BioRePeel to both New York and New Jersey practices as demand grows for no-downtime skin rejuvenation treatments.

NextBoat Inc. Completes Corporate Rebrand and Begins Trading Under "NXB" on NYSE American

Company accelerates evolution into AI-powered platform transforming how boats are bought and sold

American Marconi Wireless News - Boulevard (English)